AstraZeneca and the Bellvitge University Hospital in Spain are launching the first pilot program of the HearO™ app developed by Israel’s  Cordio Medical (see here previously) which can detect heart disease when the patient speaks on a smartphone.

https://www.einnews.com/pr_news/634340933/astrazeneca-bellvitge-university-hospital-begin-pilot-of-cordio-medical-s-app-that-monitors-heart-failure-by-voice